Variant report
Variant | nsv825154 |
---|---|
Chromosome Location | chr1:161344705-161346698 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:161179622..161180263-chr1:161343895..161344809,3 | K562 | blood: | |
2 | chr1:161166242..161168991-chr1:161344064..161345577,2 | MCF-7 | breast: | |
3 | chr1:161345136..161348126-chr1:161349827..161352612,2 | K562 | blood: | |
4 | chr1:161197030..161197783-chr1:161344152..161344865,2 | MCF-7 | breast: | |
5 | chr1:161179622..161180241-chr1:161344290..161344851,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SDHC-2 | chr1:161344552-161345130 | ENSG00000273075.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000158864 | chromatin interactions |
ENSG00000158882 | chromatin interactions |
ENSG00000158859 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs57858140 | chr1:161344741-161344742 | Weak transcription | Chromatin interactive regionlncRNA | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs183498658 | chr1:161344817-161344818 | Weak transcription | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs187171550 | chr1:161344820-161344821 | Weak transcription | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs371128318 | chr1:161344825-161344826 | Weak transcription | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs368828015 | chr1:161344829-161344830 | Weak transcription | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs531872457 | chr1:161344834-161344835 | Weak transcription | Chromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs371367943 | chr1:161344888-161344889 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs191185849 | chr1:161345017-161345018 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs539894271 | chr1:161345022-161345023 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs527698705 | chr1:161345036-161345037 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs551220533 | chr1:161345041-161345042 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs182600945 | chr1:161345074-161345075 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs138228493 | chr1:161345194-161345195 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs367890503 | chr1:161345198-161345199 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs532533336 | chr1:161345203-161345204 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs375334379 | chr1:161345204-161345205 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs187676696 | chr1:161345208-161345209 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs79805434 | chr1:161345230-161345231 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | mRNA abundance |
19 | rs76052669 | chr1:161345238-161345239 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | mRNA abundance |
20 | rs372685440 | chr1:161345304-161345305 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs113881161 | chr1:161345343-161345344 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs7542784 | chr1:161345367-161345368 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs533565628 | chr1:161345405-161345406 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs142441751 | chr1:161345406-161345407 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs577103281 | chr1:161345428-161345429 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs57270150 | chr1:161345429-161345430 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs191764964 | chr1:161345465-161345466 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs182405389 | chr1:161345472-161345473 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs79308290 | chr1:161345493-161345494 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs57007882 | chr1:161345518-161345519 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs570981615 | chr1:161345587-161345588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541429469 | chr1:161345736-161345737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187479459 | chr1:161345804-161345805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112761856 | chr1:161345826-161345827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533706105 | chr1:161345847-161345848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114196498 | chr1:161345900-161345901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563580789 | chr1:161345958-161345959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529453733 | chr1:161345963-161345964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547834669 | chr1:161345969-161345970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567831830 | chr1:161345972-161345973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192088253 | chr1:161346032-161346033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547397984 | chr1:161346090-161346091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570654753 | chr1:161346133-161346134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373033843 | chr1:161346152-161346153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558751541 | chr1:161346205-161346206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539765426 | chr1:161346216-161346217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528524962 | chr1:161346256-161346257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs202068553 | chr1:161346265-161346266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376302180 | chr1:161346272-161346273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71090386 | chr1:161346273-161346274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Breast cancer | 21045282 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20409316 | CNVD |
Mental retardation | 17847001 | CNVD |
Idiopathic thrombocytopenic purpura | 17827395 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:161321800-161348800 | Weak transcription | Gastric | stomach |
2 | chr1:161327400-161352600 | Weak transcription | Lung | lung |
3 | chr1:161328400-161359000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr1:161328600-161359000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr1:161335000-161356000 | Weak transcription | K562 | blood |
6 | chr1:161336400-161348800 | Weak transcription | Placenta | Placenta |
7 | chr1:161336600-161351600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr1:161336600-161352200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr1:161336600-161352200 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
10 | chr1:161336800-161348600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr1:161336800-161348800 | Weak transcription | Fetal Muscle Leg | muscle |
12 | chr1:161336800-161348800 | Weak transcription | Fetal Thymus | thymus |
13 | chr1:161336800-161351600 | Weak transcription | NHEK | skin |
14 | chr1:161337800-161348800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr1:161337800-161356200 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
16 | chr1:161338000-161346000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
17 | chr1:161338000-161351600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr1:161338000-161356000 | Weak transcription | GM12878-XiMat | blood |
19 | chr1:161338200-161348600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
20 | chr1:161338600-161346800 | Weak transcription | HepG2 | liver |
21 | chr1:161344400-161348800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
22 | chr1:161344600-161348800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
23 | chr1:161346400-161347000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
24 | chr1:161346400-161347000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
25 | chr1:161346400-161348200 | Enhancers | A549 | lung |
26 | chr1:161346600-161347000 | Enhancers | Muscle Satellite Cultured Cells | -- |